Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

References

• CugatiSWangJJRochtchineEMitchellPTen-year incidence of retinal vein occlusion in an older population: the Blue Mountain Eye studyArch Ophthalmol200612472673216682596
   PubMed Web of Science ®Google Scholar
• HayrehSSZimmermanBMc CarthyMJPodhajskyPSystemic diseases associated with various types of retinal occlusionAm J Ophthalmol2001131617711162981
   PubMed Web of Science ®Google Scholar
• BlondJGlacet-BernardABayaniNRetinal vein occlusion and hyperhomocysteinemiaJ Fr Opthalmol200326249253
   Web of Science ®Google Scholar
• RathEZFrankRNShinDHKimCRisk factors for retinal vein occlusion. A case-control studyOphthalmology1992995095141584567
   PubMed Web of Science ®Google Scholar
• AielloLPAveryRLArrigPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
   PubMed Web of Science ®Google Scholar
• Branch Retinal Vein Occlusion Study GroupArgon laser photocoagulation for macular edema in branch vein occlusionAm J Ophthalmol1984982712826383055
   PubMed Web of Science ®Google Scholar
• RosenfeldPJFungAEPuliafitoCAOptical cohorence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusionOphthalmic Surg Lasers Imaging20053633633916156153
   PubMed Web of Science ®Google Scholar
• AvitabileTLongoAReibaldiAIntravitreal triamcinolone compared with macular grid photocoagulation for the treatment of cystoid macular edemaAm J Ophthalmol200514069570216226521
   PubMed Web of Science ®Google Scholar
• KaracorluMKaracorluSAOzdemirHIntravitreal triamcinolone acetonide for treatment of serous macular detachment in central vein occlusionRetina2007271026103018040239
   PubMed Web of Science ®Google Scholar
• GregoriNZRosenfeldPJPuliafitoCAOne-year safety and efficacy of intravitreal triamcinolone acetonide for the managment of macular edema secondary to central vein occlusionRetina20062688989517031288
   PubMed Web of Science ®Google Scholar
• PragerFMichelsSKriechbaumKIntravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of prospective clinical trialBr J Ophthalmol20099345245619074916
   PubMed Web of Science ®Google Scholar
• AhmadiAAChuoJYBanashkevichAThe effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusionCan J Ophthalmol20094415415919491948
   PubMed Web of Science ®Google Scholar
• KimJYParkSPComparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusionKorean J Ophthalmol20092325926520046685
   PubMedGoogle Scholar
• HouJTaoYJiangYRIntravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched studyChin Med J (Eng)200912226952699
   Web of Science ®Google Scholar
• IturradleCBSpaideRFMeyerleCBIntravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term studyRetina20062627928416508427
   PubMed Web of Science ®Google Scholar
• HsuJKaiserRSSivalingamAIntravitreal bevacizuma (Avastin) in central vein occlusionRetina2007271013101918040237
   PubMed Web of Science ®Google Scholar
• RabenaMDPieramiciDJCastellarinAAIntravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusionRetina20072741942517420692
   PubMed Web of Science ®Google Scholar
• AbeggMTappeinerCWolf-SchnurrbushUTreatment of branch retinal vein occlusion induced macular edema with bevacizumabBMC Ophthalmol200881818823536
   PubMed Web of Science ®Google Scholar
• FigueroaMSContrerasINovalSArruabarrenaCResults of bevacizumab as the primary treatment for retinal vein occlusionsBr J Ophthalmol2010941052105620679089
   PubMed Web of Science ®Google Scholar
• GuthoffRMeigenTHennemannKSchraderWComparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in pair-matched analysisOphthalmologica201022431932420424494
   PubMed Web of Science ®Google Scholar
• WuLArevaloJFBerrocaiMHComparison of two doses intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 monthsRetina2009291396140319898177
   PubMed Web of Science ®Google Scholar
• AchTHoehAESchaalKBLong-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusionGraefes Arch Clin Exp Ophthalmol20092471635164119633982
   PubMed Web of Science ®Google Scholar
• FungAERosenfeldPJReichelEThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBr J Ophthalmol2006901344134916854824
   PubMed Web of Science ®Google Scholar
• RussoVBaroneAConteEBevacizumab compared with macular laser grid photocoagulation for cystiod macular edema in branch retinal vein occlusionRetina2010301324132520827152
   PubMed Web of Science ®Google Scholar
• CekicOCakırMYazıcıATA comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusionCurr Eye Res20103592592920858114
   PubMed Web of Science ®Google Scholar
• RezendeMPDiasAFOshimaAStudy of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinoloneArq Bras Oftalmol20107312913420549040
   PubMed Web of Science ®Google Scholar
• Vasconcelos-SantosDVNehemyPGSchachatAPNehemyMBSecondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factorsRetina20082857358018398360
   PubMed Web of Science ®Google Scholar
• GilliesMCIslamFMLarssonJTriamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective date from a randomised clinical trialClin Experiment Ophthalmol20103860561220528977
   PubMed Web of Science ®Google Scholar
• IslamMSVernonSANegiAIntravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 yearsEye (Lond)20072132132316543927
   PubMed Web of Science ®Google Scholar
• NomaHFunatsuHYamasakiAqueous humour of cytocines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusionEye (Lond)200822424816826241
   PubMed Web of Science ®Google Scholar
• NomaHMinamotoAFunatsuHIntravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusionGraefes Arch Exp Ophthalmol2006244309315
   PubMed Web of Science ®Google Scholar